dr. dorff on current agents for patients with mcrpc
Published 6 years ago • 150 plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
1:38
dr. dorff on role of chemotherapy in mcrpc
-
2:09
dr. hwang on choosing agents for prostate cancer treatment
-
2:18
tanya dorff, md, on how checkpoint inhibitors are being incorporated into mcrpc treatment algorithms
-
1:49
dr. ryan on bone-targeting agents for patients with prostate cancer
-
1:22
dr. twardowski on sequencing therapies for patients with mcrpc
-
10:07
new fda approved: pluvicto (lutetium-177) for advanced prostate cancer | mark scholz, md | pcri
-
17:23
cyberknife for prostate cancer | #markscholzmd #alexscholz #pcri
-
3:25
life expectancy with prostate cancer diagnosis
-
8:09
treating mcrpc with newer hormonal agents
-
0:57
dr. dorff on choosing between therapies in nonmetastatic crpc
-
2:02
dr. dorff on sequencing in metastatic castration-resistant prostate cancer
-
1:10
tanya dorff, md, regarding the role of car-t cell therapy in the management of psca mcrpc
-
8:40
additional advances in advanced prostate cancer with tanya dorff, md
-
30:08
the quality of life cost of living with advanced stage prostate cancer
-
2:11
role of sipulucel t caccines and immunotherapy in prostate cancer
-
1:13
dr. dorff on parp inhibitors in prostate cancer
-
5:37
oral hormonal agents for metastatc castration-resistant prostate cancer
-
4:56
improving the prognosis for patients with mcrpc
-
1:37
dr. tanya dorff on new car t cell therapy for prostate cancer | asco22
-
11:00
treatment approaches for newly diagnosed mcrpc
-
6:16
evolution of treatment for metastatic castration-resistant prostate cancer
-
3:58
propel and magnitude trials for mcrpc